Skip to content

Rapid Micro Biosystems RPID Change in Deferred Revenue

Change in Deferred Revenue at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$5.2M+528%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$19K-98.6%
iRadimed logo
iRadimedIRMD
$305K-44.2%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$2.61M+80.2%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$627K-208%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$766K-1,023%

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's change in deferred revenue?
Rapid Micro Biosystems (RPID) reported change in deferred revenue of $1.9M in Q1 2026.
How has Rapid Micro Biosystems's change in deferred revenue changed year-over-year?
Rapid Micro Biosystems's change in deferred revenue increased by 474.8% year-over-year, from -$507K to $1.9M.
What is the long-term trend for Rapid Micro Biosystems's change in deferred revenue?
Over 3 years (2021 to 2025), Rapid Micro Biosystems's change in deferred revenue has grown at a 19.5% compound annual growth rate (CAGR), from -$1.12M to -$1.91M.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.